6 results for “DIVISLAB”

Momentum Monthly Fact Sheet: Jan 2021

Markets retraced a bit in the first month of the year ending -2.5% down. Capitalmind Momentum was marginally up at +1.4%. Read on for a quick take on how the Momentum portfolio performed in January 2021.

Outlier in Focus - Divi's Laboratories.

We come across a large number of interesting stocks in Capitalmind SNAP Outliers, our discovery tool for stocks with momentum. Here’s a look at Divi's Laboratories, a stock we found interesting that’s been an outlier.

Earnings Report: 3QFY17 : 495 Companies Till Now With Management Comments

We Reveal The Form 483 Issued By US FDAs Inspection Of Divis Laboratories Unit-II At Visakhapatnam

Alkem Laboratories & Divis Laboratories Receive Form 483 From US FDA

FDA's New Rules Propels Generic and Biosimilar Approvals